View Older Stories

Sep 15, 2026 07:07AM Ionis Pharmaceuticals (IONS) PT Lowered to $80 at Guggenheim

Sep 8, 2026 12:43PM Ionis Pharmaceuticals (IONS) PT Lowered to $84 at Raymond James

Sep 8, 2026 09:24AM Ionis Pharmaceuticals (IONS) PT Lowered to $54 at BMO Capital Post Pelacarsen Failure

Sep 8, 2026 07:52AM Ionis Pharmaceuticals (IONS) PT Lowered to $100 at H.C. Wainwright

Sep 8, 2026 07:34AM Ionis Pharmaceuticals (IONS) PT Lowered to $85 at Canaccord

Sep 8, 2026 07:30AM Needham Reiterates Buy Rating on Ionis Pharmaceuticals (IONS)

Sep 4, 2026 06:44AM H.C. Wainwright Reiterates Buy Rating on Ionis Pharmaceuticals (IONS)

Sep 3, 2026 04:03PM FDA approves Ionis Pharma's therapy to treat rare genetic disorder

Sep 3, 2026 03:52PM FDA approves first treatment for Alexander disease

Aug 31, 2026 06:50AM H.C. Wainwright Reiterates Buy Rating on Ionis Pharmaceuticals (IONS)

Aug 31, 2026 02:41AM JPMorgan Reiterates Overweight Rating on Ionis Pharmaceuticals (IONS)

Aug 24, 2026 06:40AM Canaccord Reiterates Buy Rating on Ionis Pharmaceuticals (IONS)

Aug 19, 2026 05:32AM BMO Capital Starts Ionis Pharmaceuticals (IONS) at Market Perform

Jul 30, 2026 06:50AM Ionis Pharmaceuticals (IONS) PT Lowered to $115 at H.C. Wainwright

Jul 29, 2026 07:20AM Ionis Pharmaceuticals (IONS) Tops Q2 EPS by 37c

Jul 29, 2026 07:05AM Ionis Pharmaceuticals chief scientific officer to retire in 2027

Jul 23, 2026 07:11AM H.C. Wainwright Reiterates Buy Rating on Ionis Pharmaceuticals (IONS)

Jul 23, 2026 07:09AM Canaccord Reiterates Buy Rating on Ionis Pharmaceuticals (IONS)

Jul 21, 2026 06:47AM Ionis Pharmaceuticals (IONS) PT Lowered to $89 at Guggenheim

Jul 21, 2026 06:12AM Raymond James sees potential for beats across biopharma coverage

Jul 16, 2026 02:22AM Wolfe Research Downgrades Ionis Pharmaceuticals (IONS) to Peerperform

Jul 15, 2026 04:24AM Increasing unusual option volume: BCE EQPT MDY DOMO CC IONS ARKG FRMM TOI DINO

Jul 14, 2026 06:58AM H.C. Wainwright Reiterates Buy Rating on Ionis Pharmaceuticals (IONS)

Jul 14, 2026 06:55AM Alnylam Pharmaceuticals (ALNY) PT Raised to $485 at H.C. Wainwright

Jul 13, 2026 06:41AM BridgeBio Pharma (BBIO) PT Raised to $120 at H.C. Wainwright

Jul 13, 2026 06:41AM Ionis Pharmaceuticals (IONS) PT Lowered to $125 at H.C. Wainwright

Jul 10, 2026 06:53AM Ionis Pharmaceuticals (IONS) PT Lowered to $95 at Canaccord

Jul 10, 2026 06:06AM Ionis Pharmaceuticals (IONS) reaffirms guidance

Jul 10, 2026 05:10AM Ionis Pharmaceuticals (IONS) PT Lowered to $90 at Barclays

Jul 9, 2026 04:01PM Ionis Pharmaceuticals (IONS) PT Lowered to $100 at Citi

Jul 9, 2026 12:50PM Ionis Pharmaceuticals (IONS) PT Lowered to $90 at Jefferies

Jul 9, 2026 12:40PM Ionis Pharmaceuticals (IONS) PT Lowered to $86 at Needham

Jul 9, 2026 11:54AM Ionis Pharmaceuticals (IONS) PT Lowered to $90 at BofA Securities

Jul 9, 2026 11:53AM Ionis Pharmaceuticals (IONS) PT Lowered to $94 at TD Cowen

Jul 9, 2026 09:42AM Ionis Pharmaceuticals (IONS) PT Lowered to $92 at Oppenheimer

Jul 9, 2026 06:16AM Stifel: 'We expect IONS shares to trade lower today and ALNY shares to be volatile'

Jun 25, 2026 07:12AM Needham Reiterates Buy Rating on Ionis Pharmaceuticals (IONS)

Jun 25, 2026 06:48AM Ionis Pharmaceuticals (IONS) PT Raised to $130 at H.C. Wainwright

Jun 25, 2026 03:33AM Oppenheimer Reiterates Outperform Rating on Ionis Pharmaceuticals (IONS)

Jun 24, 2026 02:39PM FDA approves Ionis drug Tryngolza for severe hypertriglyceridemia

Jun 1, 2026 06:57AM H.C. Wainwright Reiterates Buy Rating on Ionis Pharmaceuticals (IONS)

May 27, 2026 06:44AM H.C. Wainwright Reiterates Buy Rating on Ionis Pharmaceuticals (IONS)

May 26, 2026 05:33AM Wolfe: 'Arrowhead Q3 data in acute pancreatitis will be the next big event to readthrough to Ionis. We see 74% odds of IONS stock down, 26% odds up'

Apr 30, 2026 08:39AM Ionis Pharmaceuticals (IONS) PT Raised to $100 at RBC Capital

Apr 30, 2026 07:36AM Ionis Pharmaceuticals (IONS) PT Raised to $96 at Bernstein SocGen Group

Apr 29, 2026 05:40PM Ionis Pharmaceuticals (IONS) PT Raised to $110 at Oppenheimer

Apr 29, 2026 04:10PM Ionis Pharmaceuticals (IONS) PT Raised to $86 at Stifel

Apr 29, 2026 07:10AM Ionis Pharmaceuticals (IONS) Tops Q1 EPS by 29c ; Offers Guidance

Apr 26, 2026 08:00PM U.S. Biotech stocks: Q1 earnings previews

Apr 21, 2026 07:03AM Ionis reports positive zilganersen data for Alexander disease

View Older Stories